“US-based CEOCFO magazine interview with Devonian’s President & CEO”
“Biopharma acquisition provides commercialization edge”
An editorial piece from Stockhouse’s Jeff Nielson published in February 2018.
“Farm to Pharm: the Botanical Drug Revolution”
An editorial piece from Stockhouse’s Jeff Nielson published in September 2017.
“Devonian – In The Canadian Business Quarterly”
TSX-V listed company Devonian Health Group is a late-stage botanical pharmaceutical corporation.